Corrigendum.
- Published in:
- 2017
- Publication type:
- Correction Notice
Works matching IS 20406207 AND DT 2017 AND VI 8 AND IP 9
Results: 4
1
2
Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 9, p. 245, doi. 10.1177/2040620717721459
- By:
- Publication type:
- Article
3
Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 9, p. 263, doi. 10.1177/2040620717720861
- By:
- Publication type:
- Article
4
Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 9, p. 237, doi. 10.1177/2040620717719851
- By:
- Publication type:
- Article